<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742814/" ref="ordinalpos=2617&amp;ncbi_uid=5197434&amp;link_uid=PMC3742814" image-link="/pmc/articles/PMC3742814/figure/f4-ol-06-01-0075/" class="imagepopup">Figure 4. From: Telomerase reverse transcriptase promotes the proliferation of human laryngeal carcinoma cells through activation of the activator protein 1. </a></div><br /><div class="p4l_captionBody">Effect of TERT overexpression with modulation of the p38 and ERK signaling pathways on c-Fos and c-Jun expression and activation in the HEp-2 laryngeal carcinoma cells. (A) Western blot analysis of the effect of TERT overexpression (Ad-sh-TERT) and silencing (Ad-Sh-TERT) on the p38 signaling pathway and c-Fos and c-Jun expression in the presence and absence of the p38 inhibitor, SB202190. (B) Western blot analysis of the effect of TERT overexpression (Ad-sh-TERT) and silencing (Ad-Sh-TERT) on the ERK signaling pathway and c-Fos and c-Jun expression in the presence and absence of the ERK inhibitor, U0126.</div></div>